Recently, for the treatment of patients with androgen receptor (AR)-positive, estrogen receptor (ER)-positive, HER2-negative metastatic breast cancer, the FDA has granted a fast-track designation to enobosarm (Ostarine). (1) Fast track designation aims to expedite the development and review of new drugs that are intended to treat serious or life-th
1445 Reached
Pregnant Woman with HIV-1 Infection
747 Reached1 Likes
Use of Clindamycin for Managing Bacterial Vaginosis
11227 Reached29 Comments8 Likes
Black Lesion in Old Female
1974 Reached5 Comments11 Likes
Case of Increased Risk of Pregnancy-associated Breast Cancer Recurrence
1008 Reached2 Comments
Treatment of Recurrent Adult Medulloblastoma
2602 Reached1 Comments4 Likes